Abstract
Rationale
In addition to producing robust memory impairment, benzodiazepines also induce marked sedation. Thus, it is possible that the observed amnestic effects are secondary to more global sedative effects and do not reflect a specific primary benzodiazepine effect on memory mechanisms.
Objective
The objective was to use the nonspecific stimulant d-amphetamine to dissociate the sedative and memory-impairing effects of the benzodiazepine triazolam.
Materials and methods
Single oral doses of placebo, triazolam alone (0.25, 0.50 mg/70 kg), d-amphetamine sulfate alone (20, 30 mg/70 kg), and triazolam (0.25, 0.50 mg/70 kg) and d-amphetamine sulfate (20, 30 mg/70 kg) conjointly (at all dose combinations) were administered to 18 healthy adult participants across nine sessions in a double-blind, staggered-dosing, crossover design. In addition to standard data analyses, analyses were also conducted on z-score standardized data, enabling effects to be directly compared across measures.
Results
Relative to the sedative measures, the memory measures generally exhibited a pattern of less reversal of triazolam’s effects by d-amphetamine. The memory measures ranged in degree of reversal such that the most reversal was observed for reaction time on the n-back working memory task, and the least reversal was observed for accuracy on the Sternberg working memory task, with most measures showing an overall pattern of partial reversal.
Conclusions
Benzodiazepines have specific effects on memory that are not merely a by-product of the drugs’ sedative effects, and the degree to which sedative effects contribute to the amnestic effects varies as a function of the particular memory process being assessed.
Similar content being viewed by others
References
Baddeley AD (1992) Working memory: the interface between memory and cognition. J Cogn Neurosci 4:281–288
Bishop KI, Curran HV (1995) Psychopharmacological analysis of implicit and explicit memory: a study with lorazepam and the benzodiazepine antagonist flumazenil. Psychopharmacology 121:267–278
Blin O, Simon N, Jouve E, Habib M, Gayraud D, Durand A, Bruguerolle B, Pisano P (2001) Pharmacokinetic and pharmacodynamic analysis of sedative and amnesic effects of lorazepam in healthy volunteers. Clin Neuropharmacol 24:71–81
Buffett-Jerrott SE, Stewart SH (2002) Cognitive and sedative effects of benzodiazepine use. Curr Pharm Des 8:45–58
Burns JT, House RF, Fensch FC, Miller JG (1967) Effects of magnesium pemoline and dextroamphetamine on human learning. Science 155:849–851
Curran HV (1991) Benzodiazepines, memory and mood: a review. Psychopharmacology 105:1–8
Curran HV (2000) Psychopharmacological approaches to human memory. In: Gazzaniga MS (ed) The new cognitive neurosciences, 2nd edn. Boston, MIT, pp 797–804
Curran HV, Birch B (1991) Differentiating the sedative and amnestic effects of benzodiazepines: a study with midazolam and the benzodiazepine antagonist, flumazenil. Psychopharmacology 103:519–523
Curran HV, Bond A, O’Sullivan G, Bruce M, Marks I, Lelliot P, Shine P, Lader M (1994) Memory functions, alprazolam and exposure therapy: a controlled longitudinal study of patients with agoraphobia and panic disorder. Psychol Med 24:969–976
Curran HV, Pooviboonsuk P, Dalton JA, Lader MH (1998) Differentiating the effects of centrally acting drugs on arousal and memory: an event-related potential study of scopolamine, lorazepam and diphenhydramine. Psychopharmacology 135:27–36
D’Esposito M, Postle BR, Ballard D, Lease J (1999) Maintenance versus manipulation of information held in working memory: an event-related fMRI study. Brain Cogn 41:66–86
Flavell JH (1971) What is memory development the development of? Hum Dev 14:272–278
Fleming K, Bigelow LB, Weinberger DR, Goldberg TE (1995) Neuropsychological effects of amphetamine may correlate with personality characteristics. Psychopharmacol Bull 31:357–362
Ghoneim MM (2004a) Drugs and human memory (part 1): clinical, theoretical, and methodologic issues. Anesthesiology 100:987–1002
Ghoneim MM (2004b) Drugs and human memory (part 2): clinical, theoretical, and methodologic issues. Anesthesiology 100:1277–1297
Ghoneim MM, Mewaldt SP, Berie JL, Hinrichs V (1981) Memory and performance effects of single and 3 week administration of diazepam. Psychopharmacology 73:147–151
Goodman LA, Kruskal WH (1954) Measures of association for cross-classifications. J Am Stat Assoc 49:732–764
Green JF, McElholm A, King DJ (1996) A comparison of the sedative and amnestic effects of chlorpromazine and lorazepam. Psychopharmacology 128:67–73
Griffiths RR, Bigelow GE, Liebson I (1983) Differential effects of diazepam and pentobarbital on mood and behavior. Arch Gen Psychiatry 40:865–873
Hollister LE, Müller-Oerlinghausen B, Rickels K, Shader RI (1993) Clinical uses of benzodiazepines. J Clin Psychopharmacol 13:1S–169S
Hommer D, Weingartner H, Breier A (1993) Dissociation of benzodiazepine-induced amnesia from sedation by flumazenil. Psychopharmacology 112:455–460
Hurst PM, Radlow R, Chubb NC, Bagley SK (1969) Effects of d-amphetamine on acquisition, persistence, and recall. Am J Psychol 82:307–319
Jonides J, Schumacher EH, Smith EE, Lauber EJ, Awh E, Minoshima S, Koeppe RA (1997) Verbal working memory load affects regional brain activation as measured by PET. J Cogn Neurosci 9:462–475
Justice AJH, de Wit H (2000a) Acute effects of d-amphetamine during the early and late follicular phases of the menstrual cycle in women. Pharmacol Biochem Behav 66:509–515
Justice AJH, de Wit H (2000b) Acute effects of estradiol pretreatment on the response to d-amphetamine in women. Neuroendocrinology 71:51–59
Kennedy RS, Odenheimer RC, Baltzley DR, Dunlap WP, Wood CD (1990) Differential effects of scopolamine and amphetamine on microcomputer-based performance tests. Aviat Space Environ Med 61:615–621
Keppel G (1991) Design and analysis: a research’s handbook, 3rd edn. Prentice Hall, Englewood Cliffs
Kirk T, Roache JD, Griffiths RR (1990) Dose–response evaluation of the amnestic effects of triazolam and pentobarbital in normal subjects. J Clin Psychopharmacol 10:160–167
Kornetsky C (1958) Effects of meprobamate, phenobarbital and dextroamphetamine on reaction time and learning in man. J Pharmacol Exp Ther 123:216–219
Mattay VS, Callicott JH, Bertolino A, Heaton I, Frank JA, Coppola R, Berman KF, Goldberg TE, Weinberger DR (2000) Effects of dextroamphetamine on cognitive performance and cortical activation. NeuroImage 12:268–275
Mattay VS, Goldberg TE, Fera F, Hariri AR, Tessitore A, Egan MF, Kolachana B, Callicott JH, Weinberger DR (2003) Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci USA 100:6186–6191
McLeod DR, Griffiths RR, Bigelow GE, Yingling J (1982) An automated version of the digit symbol substitution test (DSST). Behav Res Meth Instrum 14:463–466
Metcalfe J, Shimamura AP (1994) Metacognition: knowing about knowing. Cambridge, MIT
Mintzer MZ, Griffiths RR (2003) Lorazepam and scopolamine: a single-dose comparison of effects on human memory and attentional processes. Exp Clin Psychopharmacol 11:56–72
Mintzer MZ, Griffiths RR, Contoreggi C, Kimes AS, London ED, Ernst M (2001) Effects of triazolam on brain activity during episodic memory encoding: a PET study. Neuropsychopharmacology 25:744–756
Neave N, Reid C, Scholey AB, Thompson JM, Moss M, Ayre G, Wesnes K, Girdler NM (2000) Dose-dependent effects of flumazenil on cognition, mood, and cardio-respiratory physiology in healthy volunteers. Br Dent J 189:668–674
Nelson TO (1984) A comparison of current measures of the accuracy of feeling of knowing predictions. Psychol Bull 95:109–133
Postle BR, Berger JS, D’Esposito M (1999) Functional neuroanatomical double dissociation of mnemonic and executive control processes contributing to working memory performance. Proc Natl Acad Sci USA 96:12959–12964
Preston KL, Bigelow GE, Liebson IA (1989) Antagonist effects of nalbuphine in opioid-dependent human volunteers. J Pharmacol Exp Ther 248:929–937
Rapoport JL, Buchsbaum MS, Weingartner H, Zahn TP, Ludlow C, Mikkelsen EJ (1980) Dextroamphetamine. Its cognitive and behavioral effects in normal and hyperactive boys and normal men. Arch Gen Psychiatry 37:933–943
Robbins TW, Everitt BJ (1982) Functional studies of the central catecholamines. Int Rev Neurobiol 23:303–365
Smirne S, Ferini-Strambi L, Pirola R, Tancredi O, Franceschi M, Pinto P, Bareggi SR (1989) Effects of flunitrazepam on cognitive functions. Psychopharmacology 98:251–256
Snodgrass JG, Corwin J (1988) Pragmatics of measuring recognition memory: applications to dementia and amnesia. J Exp Psychol Gen 117:34–50
Soetens S, Casaer S, D’Hooge R, Hueting JE (1995) Effect of amphetamine on long-term retention of verbal material. Psychopharmacology 119:155–162
Solanto MV (1998) Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration. Behav Brain Res 94:127–152
Sternberg S (1969) The discovery of processing stages: extensions of Donder’s method. Acta Psychol 30:276–315
Tata PR, Rollings J, Collins M, Pickering A, Jacobson RR (1994) Lack of cognitive recovery following withdrawal from long-term benzodiazepine use. Psychol Med 24:203–213
Thorndike EL, Lorge I (1944) The teacher’s word book of 30,000 words. Teacher’s College, Columbia University, New York
Tulving E (1972) Episodic and semantic memory. In: Tulving E, Donaldson W (eds) Organization of memory. New York, Academic, pp 381–403
Tulving E (1983) Elements of episodic memory. Oxford University, New York
Veselis RA, Reinsel RA, Feshchenko VA (2001) Drug-induced amnesia is a separate phenomenon from sedation: electrophysiologic evidence. Anesthesiology 95:896–907
Veselis RA, Reinsel RA, Feshchenko VA, Wronski M (1997) The comparative amnestic effects of midazolam, propofol, thiopental, and fentanyl at equisedative concentrations. Anesthesiology 87:749–764
Weingartner HJ, Sirocco K, Rawlings R, Joyce E, Hommer D (1995) Dissociations in the expression of the sedative effects of triazolam. Psychopharmacology 119:27–33
Weiss B, Laties VG (1962) Enhancement of human performance by caffeine and the amphetamines. Pharmacol Rev 14:1–36
Weitzner M (1965) Manifest anxiety, amphetamine, and performance. J Psychol 60:71–79
White TL, Justice AJH, de Wit H (2002) Differential subjective effects of d-amphetamine by gender, hormone levels and menstrual cycle phase. Pharmacol Biochem Behav 73:729–741
Williams EJ (1949) Experimental designs balanced for the estimation of residual effects of treatments. Aust J Sci Res 2:149–168
Woods JH, Katz JL, Winger G (1992) Benzodiazepines: use, abuse, and consequences. Pharmacol Rev 44:151–347
Acknowledgment
This project was supported by the National Institute on Drug Abuse Research Grant DA-11936. The authors thank Crystal Barnhouser, Kristina Burns, and Koty Nadeau for protocol management, John Yingling for computer programming assistance and technical support, and Linda Felch and Paul Nuzzo for assistance with data analysis.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mintzer, M.Z., Griffiths, R.R. A triazolam/amphetamine dose–effect interaction study: dissociation of effects on memory versus arousal. Psychopharmacology 192, 425–440 (2007). https://doi.org/10.1007/s00213-007-0726-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-007-0726-y